PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Overview of attention for article published in New England Journal of Medicine, June 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 73 news outlets
blogs: 4 blogs
policy: 1 policy source
twitter: 311 X users
patent: 31 patents
facebook: 7 Facebook pages

wikipedia: 1 Wikipedia page
googleplus: 1 Google+ user
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 8 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 952 Mendeley

So far, Altmetric has seen 11 public wall posts from 7 users.

Oncology Times, 14 Oct 2020

Top read this week: The Immune System in Cutaneous Squamous Cell Carcinoma http://ow.ly/86O050A1Rmj #immunotherapy #skincancer #c…

Oncology Times, 09 Aug 2020

The Immune System in Cutaneous Squamous Cell Carcinoma http://ow.ly/86O050A1Rmj #immunotherapy #skincancer #sundaythoughts via @U…

Oncology Times, 13 Jul 2020

The Immune System in Cutaneous Squamous Cell Carcinoma http://ow.ly/86O050A1Rmj #immunotherapy #skincancer #mondaythoughts via @U…

Oncology Times, 20 Jun 2020

The Immune System in Cutaneous Squamous Cell Carcinoma http://ow.ly/86O050A1Rmj #immunotherapy #skincancer #saturdaythoughts…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 7 additional Facebook posts.